Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Potent and Selective CYP1A1 Inhibitors via Combined Ligand and Structure-Based Virtual Screening and Their in Vitro Validation in Sacchrosomes and Live Human Cells
Prashant Joshi, Glen J. P. McCann, Vinay R. Sonawane, et al.
Journal of Chemical Information and Modeling (2017) Vol. 57, Iss. 6, pp. 1309-1320
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Prioritizing Virtual Screening with Interpretable Interaction Fingerprints
Alexandre Victor Fassio, Laura Shub, Luca Ponzoni, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 18, pp. 4300-4318
Open Access | Times Cited: 28
Aryl Hydrocarbon Receptor Activation Promotes Effector CD4+ T Cell Homeostasis and Restrains Salt-sensitive Hypertension
Patrick A. Molina, Claudia Edell, Luke S. Dunaway, et al.
Function (2025)
Open Access
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
Ying Wang, Xiaomei He, Chunshi Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112235-112235
Closed Access | Times Cited: 40
Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence
Nuno R. Coelho, António B. Pimpão, Maria João Correia, et al.
Journal of Molecular Medicine (2021) Vol. 100, Iss. 2, pp. 215-243
Open Access | Times Cited: 38
Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9
Elodie Goldwaser, Catherine Laurent, Nathalie Lagarde, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 1, pp. e1009820-e1009820
Open Access | Times Cited: 23
Design, Synthesis, and Pharmacological Evaluation of Embelin–Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood–Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448
Vijay K. Nuthakki, Sushil Choudhary, Chilakala Nagarjuna Reddy, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 6, pp. 1193-1219
Closed Access | Times Cited: 12
In Silico Studies Designed to Select Sesquiterpene Lactones with Potential Antichagasic Activity from an In‐House Asteraceae Database
Chonny Herrera‐Acevedo, Luciana Scotti, Marcus Tullius Scotti
ChemMedChem (2018) Vol. 13, Iss. 6, pp. 634-645
Open Access | Times Cited: 41
Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase
Mohd Abdullaha, Vijay K. Nuthakki, Sandip B. Bharate
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112761-112761
Closed Access | Times Cited: 27
Iodine-Mediated Multicomponent Cascade Cyclization and Sulfenylation/Selenation: Synthesis of Imidazo[2,1-a]isoquinoline Derivatives
Li‐Sheng Wang, You Zhou, Shuang‐Gui Lei, et al.
Organic Letters (2022) Vol. 24, Iss. 24, pp. 4449-4453
Closed Access | Times Cited: 16
Computer-Aided (In Silico) Modeling of Cytochrome P450-Mediated Food–Drug Interactions (FDI)
Yelena Guttman, Zohar Kerem
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8498-8498
Open Access | Times Cited: 14
Computer-Aided Drug Design (CADD) to De-Orphanize Marine Molecules: Finding Potential Therapeutic Agents for Neurodegenerative and Cardiovascular Diseases
Laura Llorach-Parés, Alfons Nonell‐Canals, Conxita Àvila, et al.
Marine Drugs (2022) Vol. 20, Iss. 1, pp. 53-53
Open Access | Times Cited: 13
Methoxy-naphthyl-Linked N-Benzyl Pyridinium Styryls as Dual Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Structure–Activity Relationship
Mohd Abdullaha, Razia Banoo, Vijay K. Nuthakki, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17591-17608
Open Access | Times Cited: 6
Orally bioavailable styryl derivative of rohitukine-N-oxide inhibits CDK9/T1 and the growth of pancreatic cancer cells
Deendyal Bhurta, Md Mehedi Hossain, Mahir Bhardwaj, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115533-115533
Closed Access | Times Cited: 6
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy via screening of a natural product repository
Prashant Joshi, Vinay R. Sonawane, Ibidapo S. Williams, et al.
MedChemComm (2018) Vol. 9, Iss. 2, pp. 371-382
Open Access | Times Cited: 19
Khellinoflavanone, a Semisynthetic Derivative of Khellin, Overcomes Benzo[a]pyrene Toxicity in Human Normal and Cancer Cells That Express CYP1A1
Rajni Sharma, Ibidapo S. Williams, Linda Gatchie, et al.
ACS Omega (2018) Vol. 3, Iss. 8, pp. 8553-8566
Open Access | Times Cited: 18
Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-β structure based virtual screening
Mohd Abdullaha, Mehboob Ali, Dilpreet Kour, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103500-103500
Closed Access | Times Cited: 18
Prediction of regioselectivity and preferred order of CYP1A1-mediated metabolism: Solving the interaction of human and rat CYP1A1 forms with ligands on the template system
Yasushi Yamazoe, Kouichi Yoshinari
Drug Metabolism and Pharmacokinetics (2019) Vol. 35, Iss. 1, pp. 165-185
Closed Access | Times Cited: 17
Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors
Mohit Sharma, Ankita Sharma, Shikha Thakur, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106719-106719
Closed Access | Times Cited: 5
Visible‐Light‐Catalyzed Formal [3+2] Annulation‐Aromatization of Amidines with Isoquinolinium N‐Ylides: Access to Imidazo[2,1‐a]isoquinolines
Lvyin Zheng, Xiaoying Zou, Xiaojuan Yang, et al.
Advanced Synthesis & Catalysis (2023) Vol. 365, Iss. 21, pp. 3629-3636
Open Access | Times Cited: 5
New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2)
Carlos J. A. Ribeiro, Jayakanth Kankanala, Ke Shi, et al.
European Journal of Pharmaceutical Sciences (2018) Vol. 118, pp. 67-79
Open Access | Times Cited: 16
Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review
Baddipadige Raju, Shalki Choudhary, Gera Narendra, et al.
Drug Metabolism Reviews (2021) Vol. 53, Iss. 1, pp. 45-75
Closed Access | Times Cited: 13
Prioritizing virtual screening with interpretable interaction fingerprints
Alexandre Victor Fassio, Laura Shub, Luca Ponzoni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation
Wenxiu Sun, Xuan Sheng, Peiru Li, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Closed Access | Times Cited: 1
Photoinduced Radical Annulations of Tetrahydroisoquinoline Derivatives with 2-Benzothiazolimines: Highly Diastereoselective Synthesis of Fused Hexahydroimidazo[2,1-a]isoquinolines
Bing Yi, Wenhui Zhang, Ziqi Yi, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 18, pp. 13491-13500
Closed Access | Times Cited: 1
( E )-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent
Neill Horley, Kenneth J. M. Beresford, Supriya Kaduskar, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 24, pp. 5409-5414
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top